Confirmatory Efficacy and Safety Trial of Magnetic Seizure Therapy for Depression (CREST-MST): protocol for identification of novel biomarkers via neurophysiology

Confirmatory Efficacy and Safety Trial of Magnetic Seizure Therapy for Depression (CREST-MST): protocol for identification of novel biomarkers via neurophysiology

Abstract Background Electroconvulsive therapy (ECT) is the most effective treatment for treatment-resistant depression (TRD), especially for acute suicidal ideation, but the associated cognitive adverse effects and negative stigma limit its use. Another seizure therapy under development is magnetic...

Full description

Bibliographic Details
Main Authors: Zafiris J. Daskalakis, Shawn M. McClintock, Itay Hadas, Elisa Kallioniemi, Reza Zomorrodi, Alanah Throop, Lucy Palmer, Faranak Farzan, Kevin E. Thorpe, Carol Tamminga, Daniel M. Blumberger
Format: Article
Language:English
Published: BMC 2021-12-01
Series:Trials
Subjects:
Treatment-resistant depression
Magnetic seizure therapy
Electroconvulsive therapy
Transcranial magnetic stimulation
Electroencephalography
Cortical inhibition
Online Access:https://doi.org/10.1186/s13063-021-05873-7

Internet

https://doi.org/10.1186/s13063-021-05873-7

Similar Items